SCHEMBL25490909

SCHEMBL25490909

CC(C)(C)c1c(Cn2c3ccccc3c3ccccc32)cccc1Cn1c2ccccc2c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.48
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ CHRNE Q04844 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4A O75164 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HDAC6 Q9UBN7 2/20 0.40
▸ P2RX4 Q99571 2/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25490910 0.90 CYP19A1 (0.43) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL25490907 0.82 CYP19A1 (0.48) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL14492832 0.81 CYP19A1 (0.59) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL30616063 0.76 CHRNE (0.63) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL29093444 0.76 CHRNE (0.63) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL19652294 0.76 CYP19A1 (0.53) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL14492829 0.74 CYP19A1 (0.61) CYP19A1CYP1A2CYP2C19KDM4EALDH1A1
SCHEMBL14492825 0.72 CYP19A1 (0.53) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL12683113 0.72 CYP19A1 (0.53) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL30616060 0.72 ALDH1A1 (0.62) CYP19A1CYP1A2CYP2C19TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159578-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159578-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, OPRD1, DRD3 CYP19A1 394/4885CYP1A2 645/4885CYP2C19 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback